PHILADELPHIA – Plaintiff's lawyers hammered one message to the jury in the opening of a Xarelto (rivaroxaban) product liability trial on April 6: Bayer AG and Janssen Pharmaceuticals Inc. were silent about the increased risk of bleeding in those who take the drug with Plavix (clopidogrel) and aspirin, two other blood thinners.
Before beginning his opening statement, Brian Barr, of Levin Papantonio, placed an easel with a large pad of paper in...